Gregory N Fuller Selected Research

Gregory N Fuller Research Topics

Disease

85	Neoplasms (Cancer) 02/2022 - 01/2002
63	Glioma (Gliomas) 01/2022 - 01/2002
34	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2002
8	Astrocytoma (Pilocytic Astrocytoma) 03/2019 - 01/2002
7	Carcinogenesis 01/2020 - 12/2008
7	Brain Neoplasms (Brain Tumor) 11/2017 - 03/2002
6	Medulloblastoma 01/2021 - 03/2002
6	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2004
6	Neoplasm Metastasis (Metastasis) 09/2018 - 03/2004
6	Melanoma (Melanoma, Malignant) 07/2012 - 11/2003
5	Necrosis 09/2018 - 07/2002
5	Oligodendroglioma 11/2011 - 01/2002
4	Disease Progression 01/2022 - 07/2003
3	Ganglioneuroma 01/2020 - 06/2002
3	Neurocytoma 01/2016 - 01/2004
3	Hypoxia (Hypoxemia) 01/2016 - 07/2002
3	Infections 12/2014 - 10/2003
2	Gliosis 01/2020 - 10/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2018 - 09/2018
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 10/2018 - 05/2018
2	Chordoma 03/2018 - 10/2016
2	Adenoma (Adenomas) 05/2010 - 02/2005
2	Paraganglioma (Paragangliomas) 05/2008 - 01/2004
2	Cysts 01/2008 - 11/2005
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2005 - 09/2004
1	Choroid Plexus Carcinoma 02/2022
1	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 02/2022
1	Choroid Plexus Papilloma 02/2022

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2002
12	Insulin-Like Growth Factor Binding Protein 2IBA 01/2016 - 01/2002
10	Biomarkers (Surrogate Marker)IBA 06/2019 - 01/2009
7	MicroRNAs (MicroRNA)IBA 12/2018 - 02/2013
7	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2016 - 12/2008
7	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 05/2015 - 07/2007
6	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2013
6	Biological ProductsIBA 10/2019 - 12/2002
6	Platelet-Derived Growth FactorIBA 05/2015 - 04/2005
5	WP1066IBA 01/2022 - 09/2008
5	Therapeutic UsesIBA 01/2020 - 07/2013
5	AntigensIBA 01/2020 - 06/2007
5	Messenger RNA (mRNA)IBA 12/2018 - 01/2004
4	Phosphotransferases (Kinase)IBA 06/2019 - 09/2004
4	IntegrinsIBA 01/2019 - 05/2003
4	Transcription Factors (Transcription Factor)IBA 03/2018 - 03/2002
4	ParaffinIBA 03/2018 - 12/2002
4	Hematoxylin (Haematoxylon)IBA 11/2017 - 05/2015
4	Eosine Yellowish-(YS) (Eosin)IBA 11/2017 - 05/2015
4	Protein Isoforms (Isoforms)IBA 05/2015 - 05/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 03/2002
4	Complementary DNA (cDNA)IBA 05/2006 - 01/2002
3	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2019
3	Pharmaceutical PreparationsIBA 12/2018 - 07/2006
3	ChromatinIBA 11/2018 - 11/2011
3	Carrier Proteins (Binding Protein)IBA 11/2018 - 01/2002
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2016 - 08/2012
3	Histones (Histone)IBA 05/2015 - 11/2011
3	Insulin-Like Growth Factor Binding ProteinsIBA 02/2012 - 05/2006
3	Hormones (Hormone)IBA 01/2009 - 02/2005
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 10/2016
2	CytokinesIBA 01/2020 - 12/2014
2	ChemokinesIBA 01/2019 - 12/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2018 - 05/2008
2	Formaldehyde (Formol)FDA Link 03/2018 - 11/2003
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2018 - 01/2004
2	SurvivinIBA 02/2017 - 09/2014
2	TensinsIBA 10/2016 - 08/2004
2	ErbB Receptors (EGF Receptor)IBA 10/2016 - 08/2004
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2016 - 08/2004
2	Glial Fibrillary Acidic ProteinIBA 01/2016 - 10/2002
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2016 - 05/2008
2	S100 Proteins (S 100 Protein)IBA 01/2016 - 05/2010
2	Cyclin D1IBA 05/2015 - 03/2004
2	LigandsIBA 01/2011 - 07/2010
2	NestinIBA 12/2010 - 10/2002
2	Fibronectins (Fibronectin)IBA 07/2010 - 03/2004
2	Integrin alpha5IBA 07/2010 - 05/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2009 - 01/2009
2	Estrogen ReceptorsIBA 05/2008 - 01/2008
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2006 - 03/2002
2	CollagenIBA 12/2006 - 07/2004
2	Retinoblastoma ProteinIBA 05/2006 - 05/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004 - 07/2002
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 02/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2022
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	CateninsIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	alpha-hydroxyglutarateIBA 01/2020
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2020
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020

Therapy/Procedure

26	Therapeutics 01/2021 - 01/2002
11	Radiotherapy 02/2022 - 01/2003
9	Drug Therapy (Chemotherapy) 02/2022 - 01/2002
4	Immunotherapy 01/2020 - 06/2007
1	Adjuvant Chemotherapy 02/2022
1	Intravenous Administration 01/2020
1	Second-Look Surgery 01/2020